USFDA grants priority review to Roche’s glofitamab EP News Bureau Jan 9, 2023 If approved, glofitamab would be the first fixed-duration CD20xCD3 T-cell engaging bi-specific antibody approved to treat the most…
USFDA accepts AstraZeneca’s BLA for nirsevimab to prevent RSV lower respiratory tract disease EP News Bureau Jan 6, 2023 Nirsevimab is being developed and commercialised by AstraZeneca in collaboration with Sanofi, and is the first single-dose…
Humanigen announces positive interim data of Lenzilumab in hospitalised COVID-19 patients EP News Bureau Nov 7, 2020 The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study…